Prolx Pharmaceuticals Corp.

Organization

Tucson, AZ, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods of identifying respondents to hypoxia inducible factor 1-α...
- Patent number 7,629,128
- Issue date Dec 8, 2009
- Prolx Pharmaceuticals Corp.
- Lynn Kirkpatrick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-oxides and derivatives of melphalan for treating diseased states...
- Patent number 7,399,785
- Issue date Jul 15, 2008
- Prolx Pharmaceuticals Corp.
- Lynn Kirkpatrick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Wortmannin analogs and methods of using same
- Patent number 7,081,475
- Issue date Jul 25, 2006
- Prolx Pharmaceuticals Corp.
- Garth Powis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Asymmetric disulfides and methods of using same
- Patent number 6,552,060
- Issue date Apr 22, 2003
- Prolx Pharmaceuticals, Inc.
- D. Lynn Kirkpatrick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of redox signaling and methods of using same
- Patent number 6,372,772
- Issue date Apr 16, 2002
- Prolx Pharmaceuticals Corporation
- D. Lynn Kirkpatrick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Wortmannin Analogs and Methods of Using Same in Combination with Ch...
- Publication number 20090087441
- Publication date Apr 2, 2009
- Prolx Pharmaceuticals Corp.
- Lynn Kirkpatrick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 26

Research Projects

Information Research Project
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
- Application id 7447314
- Award notice date Jul 23, 2008
Information Research Project
PI-3 kinase inhibitor PX-866 as anticancer therapy
- Application id 7263198
- Award notice date Jun 20, 2007
Information Research Project
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
- Application id 7265290
- Award notice date Jun 11, 2007
Information Research Project
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
- Application id 7051569
- Award notice date Aug 1, 2006
Information Research Project
PI-3 kinase inhibitor PX-866 as anticancer therapy
- Application id 7159438
- Award notice date Jul 19, 2006
Information Research Project
PI-3 kinase inhibitor PX-866 as anticancer therapy
- Application id 6932660
- Award notice date Aug 1, 2005
Information Research Project
A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy
- Application id 6918549
- Award notice date Jul 25, 2005
Information Research Project
PX-12, A Molecularly Targeted Preventive Agent
- Application id 6882615
- Award notice date Mar 29, 2005
Information Research Project
Anticancer redox inhibitor,Pleurotin
- Application id 6879258
- Award notice date Mar 14, 2005
Information Research Project
A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy
- Application id 6796381
- Award notice date Jul 2, 2004
Information Research Project
PX-12, A Molecularly Targeted Preventive Agent
- Application id 6780811
- Award notice date Apr 8, 2004
Information Research Project
A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy
- Application id 6619418
- Award notice date Aug 26, 2003
Information Research Project
NOVEL ANTITUMOR DISULFIDES
- Application id 6513132
- Award notice date Aug 16, 2002
Information Research Project
NOVEL ANTITUMOR DISULFIDES
- Application id 6643009
- Award notice date Aug 16, 2002
Information Research Project
A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy
- Application id 6479873
- Award notice date Jul 29, 2002
Information Research Project
SURVIVAL SIGNALING INHIBITORS AS CANCER DRUGS
- Application id 6420494
- Award notice date Mar 1, 2002
Information Research Project
NOVEL ANTITUMOR DISULFIDES
- Application id 6376548
- Award notice date Sep 6, 2001
Information Research Project
SURVIVAL SIGNALING INHIBITORS AS CANCER DRUGS
- Application id 6287886
- Award notice date Feb 8, 2001
Information Research Project
UNIQUE THIOREDOXIN INHIBITORS AS ANTI-CANCER DRUGS
- Application id 6294814
- Award notice date Jan 24, 2001
Information Research Project
CELLECTARRAY FOR CANCER DRUG DEVELOPMENT
- Application id 6209516
- Award notice date Jun 26, 2000
Information Research Project
NOVEL ANTITUMOR DISULFIDES
- Application id 6172712
- Award notice date May 19, 2000
Information Research Project
VALIDATION AND OPTIMIZATION OF TUBULIN TARGETED DRUGS
- Application id 6020329
- Award notice date Mar 8, 2000
Information Research Project
NOVEL ANTITUMOR DISULFIDES
- Application id 2903455
- Award notice date Jul 21, 1999
Information Research Project
NOVEL BIOREDUCTIVELY ACTIVATED ALKYLATING AGENTS
- Application id 2645331
- Award notice date Sep 4, 1998
Information Research Project
NOVEL IMIDAZOLYL DISULFIDE ANTICANCER AGENTS
- Application id 2775916
- Award notice date Apr 22, 1998
Information Research Project
NOVEL IMIDAZOLYL DISULFIDE ANTICANCER AGENTS
- Application id 2431749
- Award notice date Sep 18, 1997

Prolx Pharmaceuticals Corp.

Organization

Patents Grantslast 30 patents

Methods of identifying respondents to hypoxia inducible factor 1-α...

N-oxides and derivatives of melphalan for treating diseased states...

Wortmannin analogs and methods of using same

Asymmetric disulfides and methods of using same

Inhibitors of redox signaling and methods of using same

Patents Applicationslast 30 patents

Wortmannin Analogs and Methods of Using Same in Combination with Ch...

NIH Research Projectlast 12 months

Research Projects

Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial

PI-3 kinase inhibitor PX-866 as anticancer therapy

Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial

Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial

PI-3 kinase inhibitor PX-866 as anticancer therapy

PI-3 kinase inhibitor PX-866 as anticancer therapy

A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy

PX-12, A Molecularly Targeted Preventive Agent

Anticancer redox inhibitor,Pleurotin

A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy

PX-12, A Molecularly Targeted Preventive Agent

A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy

NOVEL ANTITUMOR DISULFIDES

NOVEL ANTITUMOR DISULFIDES

A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy

SURVIVAL SIGNALING INHIBITORS AS CANCER DRUGS

NOVEL ANTITUMOR DISULFIDES

SURVIVAL SIGNALING INHIBITORS AS CANCER DRUGS

UNIQUE THIOREDOXIN INHIBITORS AS ANTI-CANCER DRUGS

CELLECTARRAY FOR CANCER DRUG DEVELOPMENT

NOVEL ANTITUMOR DISULFIDES

VALIDATION AND OPTIMIZATION OF TUBULIN TARGETED DRUGS

NOVEL ANTITUMOR DISULFIDES

NOVEL BIOREDUCTIVELY ACTIVATED ALKYLATING AGENTS

NOVEL IMIDAZOLYL DISULFIDE ANTICANCER AGENTS

NOVEL IMIDAZOLYL DISULFIDE ANTICANCER AGENTS